For decades, the pharmaceutical industry has relied on relationship building and face-to-face meetings with physicians to communicate new treatments, resources and research. Over the past decade however, pharmaceutical reps have been slowly losing regular access to physicians due to increased patient volume, physician schedules and hospital restrictions. When the coronavirus pandemic hit over two years ago, it only exacerbated this limited access to physicians. Like so many industries, big pharma has had to pivot their approach to maintaining and creating new relationships with their target audience.
B2B
eBook: How Unified Data Transforms Your Marketing Campaign
Marketers everywhere are faced with a data integrity crisis. Between new data regulations and consumers growing more and more unwilling to share,...
5 Real Examples Of How Social Audience Insights Transformed Marketing Strategies
Here at StatSocial, we recognize how essential third-party data—such as social insights—is to improving customer acquisition, engagement, and...
The Secret to Building Highly Accurate Buyer Personas
If you ask a group of marketers how they go about developing audience personas, odds are that they’ll all have varied approaches—usually a...
The Personalities of 4 Tech Giants’ Employees
This is another entry in our series unveiling something brand new for StatSocial . Our clients now have, at the ready, a mountain of B2B data...
(B2B Data) Amazon, Apple, Google, & Microsoft – Employee Demographics
Today we are unveiling something brand new for StatSocial — a mountain of B2B data married to our patented identity graph and audience intelligence...